Beta-hydroxybutyrate is a metabolic regulator of proteostasis in aging and Alzheimer disease
Ontology highlight
ABSTRACT: Beta-hydroxybutyrate (BHB) is a ketone body whose signaling effects are not well characterized. The Newman Lab has observed a shift in brain cellular protein solubility following BHB treatment in vitro and in vivo. In the brains of C57BL/6 mice that received a 7-day oral gavage of ketone ester, we have observed formation of insoluble aggregates compared to control (canola oil). In a separate analysis, we treated soluble neuronal lysate from older C57BL/6 mice with multiple concentrations of R-BHB, then separated the proteins which become insolubilized. Here we seek to understand the composition of these insoluble aggregates by mass spectrometry and which proteins remain soluble, as a function of R-BHB treatment concentration.
INSTRUMENT(S): Orbitrap Exploris 480
ORGANISM(S): Mus Musculus (ncbitaxon:10090)
SUBMITTER: Birgit Schilling
PROVIDER: MSV000091514 | MassIVE | Mon Mar 20 16:34:00 GMT 2023
SECONDARY ACCESSION(S): PXD040985
REPOSITORIES: MassIVE
ACCESS DATA